AlphaGenome is the new artificial intelligence model from Google DeepMind that can analyze the human genome and anticipate how certain mutations affect the organism. Its ability to interpret regions of DNA that were previously a mystery makes it a breakthrough for biology and medicine.
This system was developed to understand the non-coding parts of the genome, which control when and how genes are activated. Its launch has already attracted the interest of researchers, hospitals, and universities around the world.
What is AlphaGenome and why does it matter?
AlphaGenome is an AI capable of processing up to one million genetic letters at once. Thanks to its transformer-based architecture, it can detect complex functional patterns and predict thousands of biological processes.
The most innovative aspect is that it analyzes regions known as the "dark matter" of DNA. That is where many mutations linked to diseases occur.
How it predicts mutations that could cause diseases
The AI identifies genetic functions and evaluates the impact of point mutations in DNA. For example, it managed to predict alterations in the TAL1 gene, which is key in acute lymphoblastic leukemia.
This level of analysis allows AlphaGenome to anticipate which variants could trigger diseases, without the need for prior laboratory tests.
